QUAYCIAN STEWART-KODADAR: Open Payments
NPI 1265139828 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,160 in 176 payments from 19 companies in 2025. Trend: 2023 $2,161 · 2024 $2,521 · 2025 $3,160
Food & beverage: $3,160
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $582 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 21 | $320 |
| Otsuka America Pharmaceutical, Inc. | 17 | $300 |
| Neurocrine BioSciences, Inc. | 12 | $226 |
| Collegium Pharmaceutical, Inc. | 14 | $217 |
| Vanda Pharmaceuticals Inc. | 9 | $214 |
| Alkermes, Inc. | 11 | $207 |
| Axsome Therapeutics, Inc. | 7 | $180 |
| E.R. Squibb & Sons, L.L.C. | 8 | $175 |
| Corium, LLC | 8 | $170 |
Products named: VRAYLAR, CAPLYTA, INGREZZA, Jornay PM, Auvelity, COBENFY, Azstarys, ABILIFY ASIMTUFII.
Industry payments across FL — which companies pay providers there.
